Skip to content
  • Sunday, 23 August 2026
  • 1:53 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • The Uncanny "Snuffleupagus" Fish Emerges from Australian Coral Reefs
Environmental & Analytical Chemistry

The Uncanny "Snuffleupagus" Fish Emerges from Australian Coral Reefs

Abdurrohim Arsyad May 18, 2026 0

In the vibrant, shallow waters off the coast of Australia, a creature of astonishing camouflage has been unveiled to the…

Read More
Environmental & Analytical Chemistry

The Uncanny "Snuffleupagus" Fish Emerges from Australian Coral Reefs

Abdurrohim Arsyad May 18, 2026 0

A remarkable new species of ghost pipefish, colloquially dubbed the "Snuffleupagus" fish for its distinctive, trunk-like snout and uncanny camouflage,…

Read More
Environmental & Analytical Chemistry

The Uncanny "Snuffleupagus" Fish Emerges from Australian Coral Reefs

Abdurrohim Arsyad May 18, 2026 0

In the vibrant, kaleidoscopic world of Australia’s shallow marine ecosystems, a remarkable discovery has surfaced: a new species of ghost…

Read More
Unlocking the Secrets of the Arctic’s Elusive White Whales: DNA Study Reveals Surprising Mating Strategies in Bristol Bay BelugasSpace junk falls back to Earth faster as sunspot numbers climbNatural Selection Within the Testes Drives Increased Genetic Risk in Aging Fathers According to New ResearchEli Lilly Commits Up to $3.8 Billion to Acquire AtaiBeckley, Betting on the ‘God Molecule’ 5-MeO-DMT for Transformative Mental Healthcare
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ